The Repatriation General Hospital
Pharmacy E-Bulletin this week
offers an overview of the use of
abiraterone for castration-resistant
prostate cancer.
Zytiga (abiraterone acetate)
works by selectively and potently
inhibiting the enzyme 17alphadehydroxylase/
C17,20-lyase, and
was PBS-approved in Aug this year.
This week’s bulletin can be
accessed by CLICKING HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 10 Dec 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Dec 13
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.